emc易倍官网入口Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • emc易倍官网入口Press Releases
    • Media Updates
    • Media Resources
    • Media Contacts
    • emc易倍官网入口Subscribe
  • Investors arrow down
      < Back
    • Investors
    • emc易倍官网入口Investors
    • emc易倍官网入口Financial Results
    • emc易倍官网入口Annual Reports & Regulated Information
    • emc易倍官网入口Investor Events & Financial Calendar
    • Shareholder Information
    • Subscribe
    • emc易倍官网入口Ratings & Bonds
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • emc易倍官网入口Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • emc易倍官网入口Report Side Effects
    • Subscribe
  • Press shift tab to select search category
    Loading...
  •         EN  arrow_down
    • English EN
    • Fran?ais FR
  •  Global
    <
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • Brazil
    • Canada
    • United States
    • Mexico
    • Colombia
    • Australia
    • China
    • Singapore
    • South Korea
    • emc易倍官网入口 Japan
    • emc易倍官网入口 Belgium
    • emc易倍官网入口 Ukraine
    • emc易倍官网入口 UK
    • Germany
    • France
    • emc易倍官网入口 Nordics
    • Greece
    • Italy
    • emc易倍官网入口 Netherlands
    • Spain
    • emc易倍官网入口 Poland
    • Russia
    • Czech Republic
    • emc易倍官网入口 Romania
    • Hungary
    • Slovakia
    • Switzerland
    • emc易倍官网入口 Austria
    • emc易倍官网入口 UAE & Gulf
    • emc易倍官网入口 Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • emc易倍官网入口Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • emc易倍官网入口Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • emc易倍官网入口Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • emc易倍官网入口Pipeline
  • Sustainability
      < Back
    • emc易倍官网入口Sustainability
    • Sustainability
    • emc易倍官网入口Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • emc易倍官网入口Collaborate with us
  • Stories
  1. Home
  2. emc易倍官网入口Newsroom – Newsroom – Subscribe to Ipsen News

emc易倍官网入口

IPN price

€155.40

 €-2.90 (-1.83%)

  • emc易倍官网入口Media Resources
  • emc易倍官网入口Annual Report
  • emc易倍官网入口 Contacts
  • Our Locations
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • emc易倍官网入口Global Privacy Policy

? Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group global website. To continue, please click on Continue?

Continue
We value your feedback

How easy was it to navigate Ipsen website and locate the information you were seeking?







2026-08-12 11:41:58